Export

Essential medicine status
ATC codes: N03AD01
EMLc
Indication
Absence seizures, typical ICD11 code: 8A68.2
INN
Ethosuximide
Medicine type
Device
List type
Complementary
Formulations
Oral > Liquid: 250 mg per 5 mL
Oral > Solid: 250 mg
EML status history
First added in 1977 (TRS 615)
Changed in 1979 (TRS 641)
Changed in 1987 (TRS 770)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 950)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Summary of evidence and Expert Committee recommendations
The EMLc Subcommittee endorsed the inclusion of ethosuximide on the complementary list of the EMLc for treatment of absence seizures in children.